VALUE OF EARLY LUSPATERCEPT USE IN LOWER-RISK MYELODYSPLASTIC SYNDROMES

Autor: D Valcárcel, A Coughlan, SL Klijn, B White, C Franco-Villalobos, A Sichevaya, D Miteva, A Hnoosh, EM Cavalcante, A Yucel

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S443- (2024)

Objective: Patients (pts) with lower-risk myelodysplastic syndromes (LR-MDS) who are red blood cell (RBC) transfusion dependent (RBC-TD) have lower overall survival and quality of life and higher healthcare resource utilization (HCRU) than pts who ar

Externí odkaz: https://doaj.org/article/a39f4f0035f54bd694a05ede6bbcf518

Implementing Multilevel Network Meta-Regression for Time-To-Event Outcomes: A Case Study in Relapsed Refractory Multiple Myeloma.

Autor: Maciel D; PRECISIONheor, Evidence Synthesis and Decision Modeling, Vancouver, BC, Canada., Jansen JP; PRECISIONheor, Evidence Synthesis and Decision Modeling, Vancouver, BC, Canada., Klijn SL; Bristol Myers Squibb, Princeton, NJ, USA., Towle K; PRECISIONheor, Evidence Synthesis and Decision Modeling, Vancouver, BC, Canada., Dhanda D; Bristol Myers Squibb, Princeton, NJ, USA., Malcolm B; Bristol Myers Squibb, Uxbridge, England, UK., Cope S; PRECISIONheor, Evidence Synthesis and Decision Modeling, Vancouver, BC, Canada. Electronic address: shannon.cope@precisionvh.com.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Aug; Vol. 27 (8), pp. 1012-1020. Date of Electronic Publication: 2024 Apr 26.

Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models.

Autor: Reason T; Estima Scientific, Mediaworks, 191 Wood Lane, London, W12 7FP, UK. tim.reason@estima-sci.com., Benbow E; Estima Scientific, Mediaworks, 191 Wood Lane, London, W12 7FP, UK., Langham J; Estima Scientific, Mediaworks, 191 Wood Lane, London, W12 7FP, UK., Gimblett A; Estima Scientific, Mediaworks, 191 Wood Lane, London, W12 7FP, UK., Klijn SL; Bristol Myers Squibb, Princeton, NJ, USA., Malcolm B; Bristol Myers Squibb, Uxbridge, UK.

Publikováno v: PharmacoEconomics - open [Pharmacoecon Open] 2024 Mar; Vol. 8 (2), pp. 205-220. Date of Electronic Publication: 2024 Feb 10.

Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinoma.

Autor: Petersohn S; OPEN Health Evidence & Access, Marten Meesweg 107, 3068 AV Rotterdam, The Netherlands., McGregor B; The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA., Klijn SL; Bristol Myers Squibb, Sanderson Rd, Denham, Uxbridge UB8 1DH, UK., May JR; Bristol Myers Squibb, Sanderson Rd, Denham, Uxbridge UB8 1DH, UK., Ejzykowicz F; Bristol Myers Squibb, 100 Nassau Park Blvd #300, Princeton, NJ 08540, USA., Kurt M; Bristol Myers Squibb, 100 Nassau Park Blvd #300, Princeton, NJ 08540, USA., Dyer M; Bristol Myers Squibb, Sanderson Rd, Denham, Uxbridge UB8 1DH, UK., Malcolm B; Bristol Myers Squibb, Sanderson Rd, Denham, Uxbridge UB8 1DH, UK., Branchoux S; Bristol Myers Squibb, 3 Rue Joseph Monier, 92506 Rueil-Malmaison, France., Nickel K; OPEN Health Evidence & Access, Krausenstraße 8, 10117, Berlin, Germany., George S; Roswell Park Cancer Institute, 665 Elm St, Buffalo, NY 14203, USA., Kroep S; OPEN Health Evidence & Access, Marten Meesweg 107, 3068 AV Rotterdam, The Netherlands.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2023 Aug; Vol. 12 (8), pp. e230004. Date of Electronic Publication: 2023 Jul 11.

A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies.

Autor: Palmer S; Centre for Health Economics, University of York, York, England, UK., Borget I; Biostatistics and Epidemiology office, Gustave Roussy, Paris-Saclay University, Villejuif, France; Oncostat, Paris-Saclay University U1018, Inserm, Paris-Saclay University, 'Ligue Contre le Cancer' labeled team, Villejuif, France., Friede T; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany., Husereau D; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada., Karnon J; Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia., Kearns B; School of Health and Related Research, University of Sheffield, Sheffield, England, UK., Medin E; Parexel International, Stockholm, Sweden; Department of Learning, Infomatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden., Peterse EFP; Modeling & Meta-analysis, OPEN Health, Rotterdam, The Netherlands., Klijn SL; Worldwide Health Economics and Outcomes Research - Economic and Predictive Modeling, Bristol Myers Squibb, Utrecht, The Netherlands., Verburg-Baltussen EJM; Modeling & Meta-analysis, OPEN Health, Rotterdam, The Netherlands., Fenwick E; Modeling & Meta-analysis, OPEN Health, Oxford, England, UK., Borrill J; Worldwide Health Economics and Outcomes Research, Bristol Myers Squibb, Uxbridge, Greater London, England, UK. Electronic address: john.borrill@bms.com.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2023 Feb; Vol. 26 (2), pp. 185-192. Date of Electronic Publication: 2022 Aug 13.